Natixis Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Natixis Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-13,923	Closed	-$574K	–	1058
2015 Q2	$574K	Buy	13,923 +3	+0%	+$108	0.01%	882
2015 Q1	$491K	Buy	13,920 +1,047	+8%	+$35.4K	0.01%	909
2014 Q4	$414K	Buy	12,873 +158	+1%	+$4.57K	0.01%	952
2014 Q3	$357K	Sell	12,715 -1,603	-11%	-$48.8K	0.01%	953
2014 Q2	$433K	Buy	14,318 +1,911	+15%	+$52.8K	0.01%	1036
2014 Q1	$343K	Buy	12,407 +4,551	+58%	+$119K	0.01%	1044
2013 Q4	$201K	Buy	7,856 +370	+5%	+$11.4K	﹤0.01%	1122
2013 Q3	$224K	Buy	+7,486	New	+$208K	﹤0.01%	1049

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Natixis Advisors's BRLI Position: Q3 2015 in Review

Natixis Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 13,923 shares — an estimated $574K sold.

Natixis Advisors first reported a position in BRLI in Q3 2013 and held it in 8 quarters. The position peaked at $574K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Natixis Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Natixis Advisors sold 13,923 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $574K.
Natixis Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 8 quarters.
Natixis Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $574K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Natixis Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.